Affimed to Present at the Leerink Partners 6th Annual Global Healthcare Conference
Feb 08, 2017 10:01 am UTC| Business
Heidelberg, Germany, February 8, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi...
New Moringa Appetite Suppression Cap Transforming the Dietary Supplement Industry
Feb 08, 2017 10:00 am UTC| Business
SALT LAKE CITY, Feb. 08, 2017 -- A new dietary supplement capsule has harnessed the incredible power of Moringa oleifera along with other beneficial herbs and extracts. The caps, introduced into the health and wellness...
Golar LNG Partners LP Announces Pricing of Public Offering
Feb 08, 2017 09:43 am UTC| Business
Golar LNG Partners LP ("Golar Partners" or the "Partnership") (NASDAQ: GMLP) announces that it has priced its previously announced underwritten public offering of 4,500,000 common units representing limited partner...
VASCO to Showcase Mobile Customer Up Selling Innovation at Finovate Europe
Feb 08, 2017 08:00 am UTC| Business
OAKBROOK TERRACE, Ill. and LONDON, Feb. 08, 2017 -- VASCO® Data Security International, Inc. (NASDAQ:VDSI), a global leader in digital solutions including identity, security and business productivity, will demonstrate...
Xura to change company name to Mavenir Systems upon completion of Mitel Mobile acquisition
Feb 08, 2017 07:01 am UTC| Business
Mavenir brand to be showcased at Mobile World Congress 2017 WAKEFIELD, Mass., Feb. 08, 2017 -- Following the announcement in December 2016 that affiliates of Xura entered into definitive agreements to acquire Mitel...
Zealand reports Q4 2016 Lyxumia® royalty revenue
Feb 08, 2017 06:49 am UTC| Business
Company announcement - No. 3 / 2017 Zealand reports Q4 2016 Lyxumia® royalty revenue Zealand receives royalty revenue of DKK 5.3 million / €0.7 million in Q4 2016 (and DKK 24.4 million / €3.3 million in full year...
Sanofi Delivers 2016 Sales and Business EPS(1) Growth at CER(2)
Feb 08, 2017 06:44 am UTC| Business
Paris, February 8, 2017 Sanofi Delivers 2016 Sales and Business EPS(1) Growth at CER(2) Q4 2016 Change Change (CER) 2016 Change Change (CER) IFRS net sales reported €8,867m +3.3% +3.4% €33,821m ...